BNP Paribas Financial Markets Sells 27,397 Shares of Genpact Limited (NYSE:G)

BNP Paribas Financial Markets lowered its stake in Genpact Limited (NYSE:G - Free Report) by 57.1% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 20,560 shares of the business services provider's stock after selling 27,397 shares during the period. BNP Paribas Financial Markets' holdings in Genpact were worth $883,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in G. Ameriprise Financial Inc. boosted its holdings in shares of Genpact by 19.6% during the 4th quarter. Ameriprise Financial Inc. now owns 769,827 shares of the business services provider's stock worth $33,064,000 after buying an additional 126,361 shares during the period. Ancora Advisors LLC lifted its position in Genpact by 15.9% during the 4th quarter. Ancora Advisors LLC now owns 10,025 shares of the business services provider's stock worth $431,000 after acquiring an additional 1,375 shares during the last quarter. Mercer Global Advisors Inc. ADV lifted its position in Genpact by 26.4% during the 4th quarter. Mercer Global Advisors Inc. ADV now owns 73,387 shares of the business services provider's stock worth $3,152,000 after acquiring an additional 15,348 shares during the last quarter. Schonfeld Strategic Advisors LLC boosted its holdings in Genpact by 424.3% during the fourth quarter. Schonfeld Strategic Advisors LLC now owns 48,744 shares of the business services provider's stock valued at $2,094,000 after acquiring an additional 39,447 shares during the period. Finally, AdvisorShares Investments LLC acquired a new stake in shares of Genpact in the fourth quarter valued at about $469,000. Institutional investors own 96.03% of the company's stock.

Insider Activity

In other news, Director Nicholas C. Gangestad bought 2,000 shares of Genpact stock in a transaction dated Tuesday, May 13th. The shares were bought at an average price of $43.97 per share, for a total transaction of $87,940.00. Following the purchase, the director now owns 2,000 shares of the company's stock, valued at approximately $87,940. This trade represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Balkrishan Kalra sold 13,600 shares of the company's stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $48.89, for a total transaction of $664,904.00. Following the completion of the sale, the chief executive officer now directly owns 310,246 shares in the company, valued at approximately $15,167,926.94. The trade was a 4.20% decrease in their position. The disclosure for this sale can be found here. 3.07% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several research firms recently weighed in on G. Robert W. Baird cut their price objective on Genpact from $56.00 to $50.00 and set a "neutral" rating for the company in a research report on Thursday, May 8th. TD Cowen raised Genpact from a "hold" rating to a "buy" rating and increased their price objective for the company from $45.00 to $60.00 in a research report on Friday, February 7th. Mizuho raised their price objective on shares of Genpact from $45.00 to $55.00 and gave the stock a "neutral" rating in a research note on Monday, February 10th. Finally, Needham & Company LLC cut their target price on shares of Genpact from $55.00 to $50.00 and set a "buy" rating for the company in a research note on Thursday, May 8th. Four analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $50.71.

Genpact Stock Performance

Shares of G stock traded up $0.49 during mid-day trading on Tuesday, reaching $44.00. The stock had a trading volume of 1,269,309 shares, compared to its average volume of 1,368,861. Genpact Limited has a one year low of $30.38 and a one year high of $56.76. The firm has a market cap of $7.69 billion, a PE ratio of 15.49, a P/E/G ratio of 1.84 and a beta of 1.02. The firm's 50 day simple moving average is $47.15 and its 200 day simple moving average is $47.36. The company has a quick ratio of 1.85, a current ratio of 2.16 and a debt-to-equity ratio of 0.50.

Genpact (NYSE:G - Get Free Report) last issued its earnings results on Wednesday, May 7th. The business services provider reported $0.84 EPS for the quarter, topping the consensus estimate of $0.80 by $0.04. Genpact had a return on equity of 22.50% and a net margin of 10.77%. The firm had revenue of $1.21 billion during the quarter, compared to analysts' expectations of $1.21 billion. During the same period last year, the business earned $0.73 earnings per share. Genpact's quarterly revenue was up 7.4% compared to the same quarter last year. On average, analysts forecast that Genpact Limited will post 3.21 EPS for the current year.

Genpact Company Profile

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.